Studies of pain management in osteoarthritis: Bedside to policy

Osteoarthritis and Cartilage

Volumn 21, Issue 9, 2013, Pages 1264-1271

  Losina, E ^a,b,d   Dervan, E E ^a   Daigle, M E ^a   Katz, J N ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Clinical trials; Osteoarthritis; Pain; Registry

Indexed keywords

ANALGESIC AGENT; BIOLOGICAL PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; STEROID; VANILLOID RECEPTOR ANTAGONIST; VISCOSUPPLEMENT;

ANALGESIA; ARTICLE; BEHAVIOR MODIFICATION; BONE PAIN; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE DURATION; FUNDING; HEALTH CARE INDUSTRY; HEALTH CARE POLICY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SURGICAL TECHNIQUE; VISCOSUPPLEMENTATION;

CLINICAL TRIALS; OSTEOARTHRITIS; PAIN; REGISTRY;

ARTHRALGIA; CHRONIC PAIN; CLINICAL TRIALS AS TOPIC; HEALTH POLICY; HUMANS; MULTIVARIATE ANALYSIS; OSTEOARTHRITIS; PAIN MANAGEMENT; REGISTRIES; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME;

EID: 84882574713     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.04.013     Document Type: Article

References (47)

1. World Health Organization The Global Burden of Disease: 2004 Update 2008, WHO Press, Geneva, Switzerland.
2. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum Jan 2008, 58(1):26-35.
3. Prevalence and Most Common Causes of Disability Among Adults - United States, 2005 May 1, 2009, Centers for Disease Control and Prevention, Atlanta, GA.
4. Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med Oct 17 2000, 133(8):635-646.
5. Healthcare Cost and Utilization Project (HCUP). Nationwide Inpatient Sample (NIS) 2010, Agency for Healthcare Research and Quality, [accessed 12.11.2012]. http://hcupnet.ahrq.gov/.
6. White A.G., Birnbaum H.G., Janagap C., Buteau S., Schein J. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. JOccup Environ Med Sep 2008, 50(9):998-1005.
7. Woolf A.D., Akesson K. Understanding the burden of musculoskeletal conditions. The burden is huge and not reflected in national health priorities. BMJ May 5 2001, 322(7294):1079-1080.
8. Felson D.T., Lawrence R.C., Hochberg M.C., McAlindon T., Dieppe P.A., Minor M.A., et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med Nov 7 2000, 133(9):726-737.
9. Hochberg M.C., Altman R.D., Brandt K.D., Clark B.M., Dieppe P.A., Griffin M.R., et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum Nov 1995, 38(11):1535-1540.
10. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage Feb 2008, 16(2):137-162.
11. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum Sep 2000, 43(9):1905-1915.
12. Avouac J., Gossec L., Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage Aug 2007, 15(8):957-965.
13. Lee C., Straus W.L., Balshaw R., Barlas S., Vogel S., Schnitzer T.J. Acomparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum Oct 15 2004, 51(5):746-754.
14. Towheed T.E., Hochberg M.C. Asystematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum Apr 1997, 26(5):755-770.
15. Christensen R., Bartels E.M., Astrup A., Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis Apr 2007, 66(4):433-439.
16. Fransen M., McConnell S. Land-based exercise for osteoarthritis of the knee: a metaanalysis of randomized controlled trials. JRheumatol Jun 2009, 36(6):1109-1117.
17. Hernandez-Molina G., Reichenbach S., Zhang B., Lavalley M., Felson D.T. Effect of therapeutic exercise for hip osteoarthritis pain: results of a meta-analysis. Arthritis Rheum Sep 15 2008, 59(9):1221-1228.
18. Warsi A., LaValley M.P., Wang P.S., Avorn J., Solomon D.H. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum Aug 2003, 48(8):2207-2213.
19. Hawker G.A., Mian S., Bednis K., Stanaitis I. Osteoarthritis year 2010 in review: non-pharmacologic therapy. Osteoarthritis Cartilage Apr 2011, 19(4):366-374.
20. Towheed T.E., Maxwell L., Judd M.G., Catton M., Hochberg M.C., Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, (1):CD004257.
21. Hunter D.J. Osteoarthritis. Best Pract Res Clin Rheumatol Dec 2011, 25(6):801-814.
22. Golightly Y.M., Marshall S.W., Callahan L.F., Guskiewicz K. Early-onset arthritis in retired National Football League players. JPhys Act Health Sep 2009, 6(5):638-643.
23. Palmieri-Smith R.M., Thomas A.C. Aneuromuscular mechanism of posttraumatic osteoarthritis associated with ACL injury. Exerc Sport Sci Rev Jul 2009, 37(3):147-153.
24. Losina E., Weinstein A.M., Reichmann W.M., Burbine S.A., Solomon D.H., Daigle M.E., et al. Lifetime risk and age of diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res May 2013, 65(5):703-711.
25. Vlad S.C., LaValley M.P., McAlindon T.E., Felson D.T. Glucosamine for pain in osteoarthritis: why do trial results differ?. Arthritis Rheum Jul 2007, 56(7):2267-2277.
26. Wandel S., Juni P., Tendal B., Nuesch E., Villiger P.M., Welton N.J., et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010, 341:c4675.
27. Dworkin R.H., Turk D.C., Wyrwich K.W., Beaton D., Cleeland C.S., Farrar J.T., et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. JPain Feb 2008, 9(2):105-121.
28. Bellamy N., Kirwan J., Boers M., Brooks P., Strand V., Tugwell P., et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. JRheumatol Apr 1997, 24(4):799-802.
29. Viergever R.F., Ghersi D. The quality of registration of clinical trials. PloS One 2011, 6(2):e14701.
30. Zarin D.A., Tse T., Williams R.J., Califf R.M., Ide N.C. The ClinicalTrials.gov results database-update and key issues. New Engl J Med Mar 3 2011, 364(9):852-860.
31. Califf R.M., Zarin D.A., Kramer J.M., Sherman R.E., Aberle L.H., Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAm Med Assoc May 2 2012, 307(17):1838-1847.
32. Ross J.S., Mulvey G.K., Hines E.M., Nissen S.E., Krumholz H.M. Trial publication after registration in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med Sep 2009, 6(9):e1000144.
33. Reynolds T. Researchers push for publication, registration of all clinical trials. JNatl Cancer Inst Jun 4 2003, 95(11):772-774.
34. Zarin D.A., Ide N.C., Tse T., Harlan W.R., West J.C., Lindberg D.A. Issues in the registration of clinical trials. JAm Med Assoc May 16 2007, 297(19):2112-2120.
35. Peat G., McCarney R., Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis Feb 2001, 60(2):91-97.
36. Woolf A.D., Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003, 81(9):646-656.
37. Boutron I., Tubach F., Giraudeau B., Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAm Med Assoc Aug 27 2003, 290(8):1062-1070.
38. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain Nov 2001, 94(2):149-158.
39. Moore R.A., Moore O.A., Derry S., Peloso P.M., Gammaitoni A.R., Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis Feb 2010, 69(2):374-379.
40. Altman R., Brandt K., Hochberg M., Moskowitz R., Bellamy N., Bloch D.A., et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage Dec 1996, 4(4):217-243.
41. Hochberg M.C., Altman R.D., Brandt K.D., Clark B.M., Dieppe P.A., Griffin M.R., et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum Nov 1995, 38(11):1541-1546.
42. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P.A., et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis Dec 2003, 62(12):1145-1155.
43. Turk D.C., Dworkin R.H., McDermott M.P., Bellamy N., Burke L.B., Chandler J.M., et al. Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain Oct 31 2008, 139(3):485-493.
44. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI initiative: osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage May 2004, 12(5):389-399.
45. Tunis S.R., Stryer D.B., Clancy C.M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAm Med Assoc Sep 24 2003, 290(12):1624-1632.
46. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ May 11 1996, 312(7040):1215-1218.
47. Paltiel A.D., Fuhlbrigge A.L., Kitch B.T., Liljas B., Weiss S.T., Neumann P.J., et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. JAllergy Clin Immunol Jul 2001, 108(1):39-46.